AI-Discovered New Substance Shows Therapeutic Effect Against Antibiotic-Resistant Salmonella
Announcement by the National Honam Regional Biological Resources Center under the Ministry of Climate, Energy and Environment
Selection of peptides based on genetic information from wild organisms
New substances discovered using artificial intelligence (AI) have shown efficacy against antibiotic-resistant Salmonella, suggesting a new possibility for the treatment of inflammatory bowel disease.
The National Honam Regional Biological Resources Center under the Ministry of Climate, Energy and Environment announced on the 19th that it has confirmed that a new peptide identified through AI analysis suppresses Salmonella strains resistant to existing antibiotics and alleviates intestinal inflammation.
Peptides are very small protein fragments and are bio-derived substances that perform various physiological functions, including intercellular signal transmission, immune regulation, and tissue repair. Based on large-scale genetic information obtained from wild organisms inhabiting islands and coastal areas, the research team used AI technology to select peptides predicted to have excellent antimicrobial properties. Through stepwise experimental validation, they then discovered new drug candidate substances more quickly and precisely than with conventional methods.
This study was conducted jointly by the Advanced Island Wild Organism Resources Research Group at the center, the College of Pharmacy at Chonnam National University, Insilicogen, and the Functional Platform Research Group at the Korea Food Research Institute. The research was carried out as part of the Multi-Ministerial National BioResource Project for Advanced Utilization, in which the Korea Environmental Industry & Technology Institute participates as a specialized agency.
Exterior view of the National Honam Regional Biological Resources Center located in Mokpo, Jeollanam-do. National Honam Regional Biological Resources Center
View original imageThe results showed that the peptide effectively alleviated intestinal inflammation caused by Salmonella infection, regulated the secretion of inflammation-inducing substances, and at the same time protected the intestinal mucosa. The reduction rate of intestinal disease was 89.17%, higher than 87.78% achieved by ciprofloxacin, an existing antibiotic.
Salmonella infectious colitis is a common disease in both humans and livestock, and its treatment has become increasingly difficult in recent years due to the rise of antibiotic-resistant strains. In livestock in particular, it leads to growth retardation and higher mortality rates, which in turn cause decreased livestock productivity and increased disease control costs.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Director Park Jinyoung said, "This is a meaningful achievement that offers a new alternative for intestinal diseases that are difficult to treat because of antibiotic-resistant bacteria," adding, "We will expand the application of AI-based peptide discovery technology and continue additional research for practical use."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.